Selected Balance Sheet Data - Changes in Carrying Amount of Goodwill (Details) $ in Thousands |
9 Months Ended |
---|---|
Mar. 31, 2022
USD ($)
| |
Beginning balance | $ 843,067 |
Acquisitions | 4,407 |
Eminence impairment | (8,275) |
Currency translation | (2,767) |
Ending balance | 827,618 |
Protein Sciences [Member] | |
Beginning balance | 392,717 |
Eminence impairment | (8,275) |
Currency translation | (2,588) |
Ending balance | 381,854 |
Diagnostics and Genomics [Member] | |
Beginning balance | 450,350 |
Acquisitions | 4,407 |
Currency translation | (179) |
Ending balance | $ 445,764 |
X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount after tax of loss recognized that results from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|